Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 452107, 6 pages
http://dx.doi.org/10.1155/2013/452107
Clinical Study

Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy: An Eight-Year Single Center Experience

1Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, No. 7, Chung Shan S. Road (Zhongshan S. Road), Zhongzheng District, Taipei City 10002, Taiwan
2Department of Urology, Cardinal Tien Hospital, College of Medicine, Fu Jen Catholic University, No. 362, Zhongzheng Road, Xindian District, New Taipei City 231, Taiwan
3Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, No. 21, Section 2, Nanya S. Road, Banqiao District, New Taipei City 220, Taiwan
4Department of Urology, Tzu Chi General Hospital, No. 707, Section 3, Chung Yang Road, Hualien 970, Taiwan

Received 18 August 2013; Accepted 1 October 2013

Academic Editors: R. L. Davis and W. Kassouf

Copyright © 2013 Bing-Juin Chiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. C. Shandera, G. P. Thibault, and G. E. Deshon Jr., “Variability in patient preparation for prostate biopsy among American urologists,” Urology, vol. 52, no. 4, pp. 644–646, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Gerald and J. E. B. Mandell, Raphael Dolin: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Philadelphia, Pa, USA, 7th edition, 2010.
  3. A. Heidenreich, M. Bolla, S. Joniau et al., Guidelines on Prostate Cancer, European Association of Urology, 2010.
  4. Taiwan Cooperative Oncology Group, National Health Research Institutes: Clinical Guidelines on Prostate Cancer, 3rd edition, 2010.
  5. P. de Lajudie, F. Roquet, M. Reynier, and P. Adamowicz, “Study of a new synthetic antibacterial agent: 8-ethyl-5-oxo-2-piperaziny 5,8-dihydro-(2,3-d)pyrimidine-6-carboxylic acid (pipemidic acid),” Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences D, vol. 279, no. 25, pp. 1931–1934, 1974. View at Google Scholar · View at Scopus
  6. B. C. Griffith, A. F. Morey, M. M. Ali-Khan, E. Canby-Hagino, J. P. Foley, and T. A. Rozanski, “Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk,” Journal of Urology, vol. 168, no. 3, pp. 1021–1023, 2002. View at Google Scholar · View at Scopus
  7. National Committee for Clinical Laboratory Standards, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, National Committee for Clinical Laboratory Standards, Villanova, Pa, USA, 5th edition, 2000.
  8. R. Tal, P. M. Livne, D. M. Lask, and J. Baniel, “Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy,” Journal of Urology, vol. 169, no. 5, pp. 1762–1765, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Lange, C. Zappavigna, R. Hamidizadeh, S. L. Goldenberg, R. F. Paterson, and B. H. Chew, “Bacterial sepsis after prostate biopsy—a new perspective,” Urology, vol. 74, no. 6, pp. 1200–1205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. M. Thompson, J. P. Pryor, J. P. Williams et al., “The problem of infection after prostatic biopsy: the case for the transperineal approach,” British Journal of Urology, vol. 54, no. 6, pp. 736–740, 1982. View at Google Scholar · View at Scopus
  11. W. V. Kern, E. Andriof, M. Oethinger, P. Kern, J. Hacker, and R. Marre, “Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 4, pp. 681–687, 1994. View at Google Scholar · View at Scopus
  12. M. Kresken, D. Hafner, H. Mittermayer et al., “Prevalence of fluoroquinolone resistance in Europe,” Infection, vol. 22, no. 2, pp. S90–S98, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. K. Otrock, G. O. Oghlakian, M. M. Salamoun, M. Haddad, and A. R. N. Bizri, “Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon,” Infection Control and Hospital Epidemiology, vol. 25, no. 10, pp. 873–877, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Zervos, E. Hershberger, D. P. Nicolau et al., “Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000,” Clinical Infectious Diseases, vol. 37, no. 12, pp. 1643–1648, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Binsaleh, M. Al-Assiri, S. Aronson, and A. Steinberg, “Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting?” The Canadian Journal of Urology, vol. 11, no. 4, pp. 2352–2353, 2004. View at Google Scholar · View at Scopus
  16. A. Hoshi, M. Nitta, S. Hongoh et al., “Sepsis following transrectal prostate biopsy: a report of 2 cases and reviewed similar cases in Japan,” Acta Urologica Japonica, vol. 52, no. 8, pp. 645–649, 2006. View at Google Scholar · View at Scopus
  17. T. Miura, K. Tanaka, K. Shigemura, Y. Nakano, A. Takenaka, and M. Fujisawa, “Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature,” International Journal of Urology, vol. 15, no. 5, pp. 457–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. W.-H. Sheng, Y.-C. Chen, J.-T. Wang, S.-C. Chang, K.-T. Luh, and W.-C. Hsieh, “Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan,” Diagnostic Microbiology and Infectious Disease, vol. 43, no. 2, pp. 141–147, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. L. Young, M. A. Liss, and R. J. Szabo, “Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy,” Urology, vol. 74, no. 2, pp. 332–338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Feliciano, E. Teper, M. Ferrandino et al., “The incidence of fluoroquinolone resistant infections after prostate biopsy–are fluoroquinolones still effective prophylaxis?” Journal of Urology, vol. 179, no. 3, pp. 952–955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Hori, A. Sengupta, A. Joannides, B. Balogun-Ojuri, R. Tilley, and J. McLoughlin, “Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk?” BJU International, vol. 106, no. 9, pp. 1298–1302, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. S. Jeon, S.-H. Woo, J.-H. Hyun, H. Y. Choi, and S. E. Chai, “Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy,” Urology, vol. 62, no. 3, pp. 461–466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-H. Lee, S.-M. Chen, C.-R. Ho, P.-L. Chang, C.-L. Chen, and K.-H. Tsui, “Risk factors associated with transrectal ultrasound guided prostate needle biopsy in patients with prostate cancer,” Chang Gung Medical Journal, vol. 32, no. 6, pp. 623–627, 2009. View at Google Scholar · View at Scopus
  24. D. S. Park, J. J. Oh, J. H. Lee, W. K. Jang, Y. K. Hong, and S. K. Hong, “Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy,” Advances in Urology, vol. 2009, Article ID 750598, 4 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. Livermore, D. James, M. Reacher et al., “Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999,” Emerging Infectious Diseases, vol. 8, no. 5, pp. 473–478, 2002. View at Google Scholar · View at Scopus
  26. J. Gilad, A. Borer, N. Maimon, K. Riesenberg, M. Klein, and F. Schlaeffer, “Failure of ciprofloxacin prophylaxis for ultrasound guided transrectal prostatic biopsy in the era of multiresistant enterobacteriaceae,” Journal of Urology, vol. 161, no. 1, p. 222, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Patel and R. Kirby, “Infections after prostate biopsy and antibiotic resistance,” BJU International, vol. 101, no. 10, pp. 1201–1202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Batura, G. G. Rao, P. Bo Nielsen, and A. Charlett, “Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates,” BJU International, vol. 107, no. 5, pp. 760–764, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Gruson, G. Hilbert, F. Vargas et al., “Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 3, pp. 837–843, 2000. View at Google Scholar · View at Scopus
  30. F. Wagenlehner, J. Stöwer-Hoffmann, W. Schneider-Brachert, K. G. Naber, and N. Lehn, “Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology,” International Journal of Antimicrobial Agents, vol. 15, no. 3, pp. 207–211, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Batura, G. G. Rao, and P. B. Nielsen, “Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy,” BJU International, vol. 106, no. 7, pp. 1017–1020, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. S. Wolf Jr., C. J. Bennett, R. R. Dmochowski, B. K. Hollenbeck, M. S. Pearle, and A. J. Schaeffer, “Best practice policy statement on urologic surgery antimicrobial prophylaxis,” Journal of Urology, vol. 179, no. 4, pp. 1379–1390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. M. Thompson, J. Philpott-Howard, and W. Wang, “Is the current antibiotic prophylaxis policy in transrectal prostate biopsy still safe?” BJU International, vol. 104, no. 2, pp. 271–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Chappell and T. O'Brien, “Infections after prostate biopsy and antibiotic resistance,” BJU International, vol. 103, no. 3, p. 409, 2009. View at Publisher · View at Google Scholar · View at Scopus